dizziness, fast heartbeats
5d), and western blot (Fig
2.1% (consistent with weight loss rate) No Safety Signals: No increased risk of pancreatitis, thyroid tumors, or major CV events Historic Achievement: REDEFINE-1 demonstrated that CagriSema produces the highest mean weight loss (22.7%) ever reported for an obesity pharmacotherapy in a Phase 3 trial
Cardiology consultation should be considered for patients with complex cardiovascular disease when questions arise about the appropriateness of continuing GLP-1 therapy in the context of heart rate changes
Packed with Nutrition Vitamins, minerals, and antioxidants from 40+ fruits, vegetables, and superfoods Contains LactoSpore Probiotics Formulated to relieve occasional gas, bloating, constipation, and diarrhea